+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Medical Devices, Pharmaceutical), by Region (North America, Europe, Asia Pacific, Latin America, MEA), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 160 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5415419
The global healthcare contract manufacturing market size is expected to reach USD 512.7 billion by 2030, expanding at a CAGR of 9.6% during the forecast period. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. Many companies witnessed losses in sales and operating profit during the COVID-19 pandemic. As per Jabil, Inc., COVID-19 has increased expenses, primarily related to additional labor costs and procurement of PPE for employees globally, and has caused a reduction in factory utilization due to travel disruptions and restrictions.



Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence we can say that the pandemic has had a positive impact on this industry.

Increasing demand for advanced products is another major factor driving the industry scale. Original equipment manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Healthcare Contract Manufacturing Market Report Highlights

  • The pharmaceutical segment dominated the market with a share of 74.8% in 2021 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings.
  • The medical devices segment is expected to be the fastest-growing segment with a CAGR of 11.7% owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market.
  • Cardiology is the dominant segment in the medical device contract manufacturing market owing to the rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions.
  • Asia Pacific is the dominant region with a share of 45.7% in 2021 and is expected to witness lucrative growth owing to the presence of a large number of service providers, lower costs and growing demand for medical devices in the region.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective-1:
1.10.2 Objective-2:
1.10.3 Objective-3:
1.10.4 Objective-4:
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3. Healthcare Contract Manufacturing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Industry Value Chain Analysis
3.3.1 Pharmaceutical contract manufacturing
3.3.2 Medical device contract manufacturing
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Implementation of international standards by contract manufacturers
3.4.1.2 Drug shortage driving the demand for pharmaceutical development
3.4.1.3 Commercial success of biologics for clinical use
3.4.2 Market Restraint Analysis
3.4.2.1 Regulatory and legal compliance
3.4.2.2 Threat of information loss
3.4.3 Industry Challenges
3.4.3.1 Managing relationships
3.5 Contract Manufacturing Market Analysis Tools
3.5.1 Porter’s Five Forces Analysis
3.5.2 PESTEL Analysis
3.5.3 Major Deals & Strategic Alliances Analysis
3.5.3.1 Mergers and acquisitions
3.5.3.2 Geographic expansion
3.5.3.3 Partnership
3.5 Impact of Covid-19 on Healthcare Contract Manufacturing Market
Chapter 4. Healthcare Contract Manufacturing Market: Type Segment Analysis
4.1 Healthcare Contract Manufacturing: Market Share Analysis, 2021 & 2030
4.2 Medical Device
4.2.1 Medical device market, 2017-2030 (USD Billion)
4.2.2 Service
4.2.2.1 Accessories manufacturing
4.2.2.1.1 Accessories manufacturing market, 2017-2030 (USD Billion)
4.2.2.2 Assembly manufacturing
4.2.2.2.1 Assembly manufacturing market, 2017-2030 (USD Billion)
4.2.2.3 Component manufacturing
4.2.2.3.1 Component manufacturing market, 2017-2030 (USD Billion)
4.2.2.4 Device manufacturing
4.2.2.4.1 Device manufacturing market, 2017-2030 (USD Billion)
4.2.3 Therapeutic area
4.2.3.1 Cardiology
4.2.3.1.1 Cardiology market, 2017-2030 (USD Billion)
4.2.3.2 Diagnostic imaging
4.2.3.2.1 Diagnostic imaging market, 2017-2030 (USD Billion)
4.2.3.3 Orthopedic
4.2.3.3.1 Orthopedic market, 2017-2030 (USD Billion)
4.2.3.4 IVD
4.2.3.4.1 IVD market, 2017-2030 (USD Billion)
4.2.3.5 Ophthalmic
4.2.3.5.1 Ophthalmic market, 2017-2030 (USD Billion)
4.2.3.6 General & plastic surgery
4.2.3.6.1 General & plastic surgery market, 2017-2030 (USD Billion)
4.2.3.7 Drug delivery
4.2.3.7.1 Drug delivery market, 2017-2030 (USD Billion)
4.2.3.8 Dental
4.2.3.8.1 Dental market, 2017-2030 (USD Billion)
4.2.3.9 Endoscopy
4.2.3.9.1 Endoscopy market, 2017-2030 (USD Billion)
4.2.3.10 Diabetes care
4.2.3.10.1 Diabetes care market, 2017-2030 (USD Billion)
4.2.3.11 Others
4.2.3.11.1 Others market, 2017-2030 (USD Billion)
4.3 Pharmaceutical
4.3.1 Pharmaceutical market, 2017-2030 (USD Billion)
4.3.2 Service
4.3.2.1 API/bulk drugs
4.3.2.1.1 API/bulk drugs market, 2017-2030 (USD Billion)
4.3.2.2 Advanced drug delivery formulations
4.3.2.2.1 Advanced drug delivery formulations market, 2017-2030 (USD Billion)
4.3.2.3 Packaging
4.3.2.3.1 Packaging market, 2017-2030 (USD Billion)
4.3.2.4 Finished dose formulations
4.3.2.4.1 Finished dose formulations market, 2017-2030 (USD Billion)
4.3.2.4.2 Solid
4.3.2.4.2.1 Solid market, 2017-2030 (USD Billion)
4.3.2.4.3 Liquid
4.3.2.4.3.1 Liquid market, 2017-2030 (USD Billion)
4.3.2.4.4 Semisolid formulations
4.3.2.4.4.1 Semisolid formulations market, 2017-2030 (USD Billion)77
Chapter 5. Healthcare Contract Manufacturing Market: Regional Analysis
5.1 Healthcare Contract Manufacturing: Regional Market Share
5.2 Healthcare Contract Manufacturing: Market Share Analysis, 2021 & 2030
5.3 North America
5.3.1 North America Healthcare Contract Manufacturing market, 2017-2030 (USD Billion)
5.3.2 U.S.
5.3.2.1 U.S. healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.3.3 Canada
5.3.3.1 Canada healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4 Europe
5.4.1 Europe Healthcare Contract Manufacturing market, 2017-2030 (USD Billion)
5.4.2 U.K.
5.4.2.1 U.K. healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.3 Germany
5.4.3.1 Germany healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.4 France
5.4.4.1 France healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.5 Italy
5.4.5.1 Italy healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.6 Spain
5.4.6.1 Spain healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.7 Russia
5.4.7.1 Russia healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.8 Belgium
5.4.8.1 Belgium healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.9 Netherlands
5.4.9.1 Netherlands healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.10 Switzerland
5.4.10.1 Switzerland healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.4.11 Sweden
5.4.11.1 Sweden healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5 Asia Pacific
5.5.1 Asia Pacific Healthcare Contract Manufacturing market, 2017-2030 (USD Billion)
5.5.2 India
5.5.2.1 India healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.3 Japan
5.5.3.1 Japan healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.4 China
5.5.4.1 China healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.5 South Korea
5.5.5.1 South Korea healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.6 Australia
5.5.6.1 Australia healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.7 Indonesia
5.5.7.1 Indonesia healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.8 Malaysia
5.5.8.1 Malaysia healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.9 Singapore
5.5.9.1 Singapore healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.10 Thailand
5.5.10.1 Thailand healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.5.11 Taiwan
5.5.11.1 Taiwan healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.6 Latin America
5.6.1 Latin America Healthcare Contract Manufacturing market, 2017-2030 (USD Billion)
5.6.2 Brazil
5.6.2.1 Brazil healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.6.3 Mexico
5.6.3.1 Mexico healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.6.4 Argentina
5.6.4.1 Argentina healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.6.5 Colombia
5.6.5.1 Colombia healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.6.6 Chile
5.6.6.1 Chile healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.7 MEA
5.7.1 MEA Healthcare Contract Manufacturing market, 2017-2030 (USD Billion)
5.7.2 South Africa
5.7.2.1 South Africa healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.7.3 Saudi Arabia
5.7.3.1 Saudi Arabia healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.7.4 UAE
5.7.4.1 UAE healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.7.5 Israel
5.7.5.1 Israel healthcare contract manufacturing market, 2017-2030 (USD Billion)
5.7.6 Egypt
5.7.6.1 Egypt healthcare contract manufacturing market, 2017-2030 (USD Billion)
Chapter 6. Company Profiles
6.1 Company Profiles
6.1.1 Nordson MEDICAL
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Service benchmarking
6.1.1.4 Strategic initiatives
6.1.2 INTEGER HOLDINGS CORPORATION
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Service benchmarking
6.1.2.4 Strategic initiatives
6.1.3 JABIL INC.
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Service benchmarking
6.1.3.4 Strategic initiatives
6.1.4 VIANT
6.1.4.1 Company overview
6.1.4.2 Service benchmarking
6.1.4.3 Strategic initiatives
6.1.5 FLEX LTD.
6.1.5.1 Company overview
6.1.5.2 Financial performance
6.1.5.3 Service benchmarking
6.1.5.4 Strategic initiatives
6.1.6 CELESTICA INC.
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Service benchmarking
6.1.6.4 Strategic initiatives
6.1.7 SANMINA CORPORATION
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Service benchmarking
6.1.7.4 Strategic initiatives
6.1.8 PLEXUS CORP.
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Service benchmarking
6.1.8.4 Strategic initiatives
6.1.9 PHILLIPS MEDISIZE
6.1.9.1 Company overview
6.1.9.2 Service benchmarking
6.1.9.3 Strategic initiatives
6.1.10 WEST PHARMACEUTICAL SERVICES, INC.
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Service benchmarking
6.1.10.4 Strategic initiatives
6.1.11 SYNECCO
6.1.11.1 Company overview
6.1.11.2 Service benchmarking
6.1.12 CATALENT, INC
6.1.12.1 Company overview
6.1.12.2 Financial performance
6.1.12.3 Service benchmarking

Companies Mentioned

  • Nordson Medical
  • Integer Holdings Corporation
  • Jabil Inc.
  • Viant
  • Flex Ltd.
  • Celestica Inc.
  • Sanmina Corporation
  • Plexus Corp.
  • Phillips Medisize
  • West Pharmaceutical Services, Inc.
  • Synecco
  • Catalent, Inc

Methodology

Loading
LOADING...